Trump's FDA nominee says MMR vaccine safe and effective at Senate hearing

Why This Matters

• Overton's confirmation comes amid a measles outbreak that has put pressure on the administration to clarify its stance on vaccination.
• Her testimony could influence public confidence in vaccine safety, especially among Trump supporters who may have been swayed by his earlier remarks.
• The outcome of the hearing will determine who leads the FDA at a critical time for public health and drug regulation.

Background

Overton is Trump's pick to head the FDA, a position requiring Senate confirmation. Her nomination has drawn attention because of her association with Trump's anti-vaccine rhetoric. In August 2026, Trump signed an executive order that included questioning the safety of the MMR shot, with Overton present. The measles outbreak has been spreading in parts of the US, with health officials urging vaccination as the primary preventive measure.

Key Perspectives

Dr Heidi Overton: The nominee emphasized the safety and effectiveness of the MMR vaccine and its role in the current outbreak response, aligning with medical consensus. President Donald Trump: Trump has previously cast doubt on the vaccine, calling it 'quite lethal' in an August statement, creating a conflict with his nominee's testimony. Public health experts: The medical community overwhelmingly supports the MMR vaccine as safe and effective, and will likely view Overton's remarks as a positive step toward restoring confidence.

What to Watch

• The Senate's vote on Overton's confirmation, which could be delayed by concerns over her independence from Trump's anti-vaccine stance.
• Future statements from Trump or Overton that may clarify the administration's official position on vaccines.
• Data on measles outbreak containment, which may be used to measure the impact of federal messaging on vaccination rates.